Parkinson's Disease Center and Movement Disorders Clinic

Click on the Expand plus sign sign to list the poster and platform presentations by year. Then click on the link to view that presentation.

2023

Collapse All | Expand All

 

    Movement Disorder Society (MDS)
    27th International Congress of Parkinson's Disease and Movement Disorders in Copenhagen, Denmark (Aug. 27-31, 2023)
    • Evoked resonant neural activity in globus pallidus vs. subthalamic nucleus of patients with Parkinson's disease, preliminary results.

      Branco L, Swamy C, Tarakad A, Vanegas-Arroyave N, Patel I, Ince N, et al.

    • Deep brain stimulation in chorea: Four cases and literature review.

      Hull M, Parnes M, Tarakad A

    • A phase 2, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ABP-450 (prabotulinumtoxinA) in adults with isolated cervical dystonia.

      Jankovic J, Oh C, Liu Y, Comella C

    • Apathy and Parkinson?s disease motor phenotypes: A preliminary study.

      Lenka A, Gazes Y, Vanegas-Arroyave N

    • Identifying neural biomarkers of motivated behavior in Parkinson's disease using sensing-capable DBS devices.

      Provenza N, Rajesh S, Diab N, Reddy S, Lamichhane B, Sabharwal A, et al.

    • Exploring the effects of spinal cord stimulation for gait disturbances in Parkinson's disease.

      Vanegas-Arroyave N, Kwei K, Lee M, Prakash C, Branco L, Tarakad A, et al.

    • Apathy, white-matter microstructure, and effort-based decision making in Parkinson's disease.

      Vanegas-Arroyave N, Leheron C, He Z, Lee S, Huey E, Gazes Y

    American Academy of Neurology (AAN)
    75th Annual Meeting in Boston, Mass. (April 22-28, 2023)
    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    • Spinocerebellar ataxia 21 and phenotypic variability within a single family.

      Hull M, Parnes M, Jankovic J

    • Apathy and Parkinson's disease motor phenotypes: A preliminary study.

      Lenka A, Gazes Y, Vanegas-Arroyave N

    • Precision neurology for dementia.

      Shulman J, Vanegas-Arroyave N, Fong J, Elsea S, Lin C, Saade H, et al.

2022

Collapse All | Expand All

 

    Movement Disorder Society (MDS)
    26th International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain (Sept. 15-18, 2022)
    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis subtype of cervical dystonia.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with retrocollis subtype of cervical dystonia.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    • Spinocerebellar ataxia 21 and phenotypic variability within a family.

      Hull M, Parnes M, Jankovic J

    • Neuroanatomical underpinnings of apathy in Parkinson's disease.

      Le Heron C, Huey E, Vanegas-Arroyave N, Gazes Y, Lee S

    • How does head tremor in cervical dystonia change with head position?

      Vu J, Cisneros E, Zhao J, Jankovic J, Factor S, Goetz C, et al.

    International Neurotoxin Association (INA)
    Toxins 2022 6th International Conference in New Orleans, La. (July 27-30, 2022)
    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    American Academy of Neurology (AAN)
    74th Annual Meeting in Seattle, Wash. (April 2-7, 2022)
    • Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.
      [Previously Presented]

      Jankovic J, Carruthers J, Naumann M, Boodhoo T, Gupta S, Attar M, et al.

    • A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.

      Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

<2021

Collapse All | Expand All